Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04994821 · ClinicalTrials.gov registry record · Phase 2
TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study
A Phase 2 study, sponsored by Soterix Medical.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT04994821 is a Phase 2 study that has completed, run by Soterix Medical. The registered enrollment target is 60 participants.
The verdict
NCT04994821, a Phase 2 study, has completed, sponsored by Soterix Medical.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation in which low level electrical currents are applied to the scalp in order to alter brain function. In a prior Phase-I study, the research team demonstrated feasibility of self-administration of a home-tDCS prototype in 14 patients that applied 15 sessions for each patient at an outpatient center.
Interventions
- BEHAVIORAL Cognitive Reappraisal
- DEVICE transcranial direct current stimulator (tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-09-28 |
| Est. Completion | 2022-09-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04994821
The ClinicalTrials.gov registry entry for NCT04994821 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Soterix Medical, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cognitive Reappraisal is the first listed.
NCT04994821 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04994821 about?
NCT04994821 is a clinical study titled "TDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study". Transcranial direct current stimulation (tDCS) is a form of non-invasive brain stimulation in which low level electrical currents are applied to the scalp in order to alter brain function. In a prior Phase-I study, the research team demonstrated feasibility of self-administration of a home-tDCS prot...
What is the current status of trial NCT04994821?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2020-09-28. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT04994821?
The interventions under investigation include: Cognitive Reappraisal (BEHAVIORAL), transcranial direct current stimulator (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT04994821?
This trial is sponsored by Soterix Medical, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.